Badriah Abdullah Hifni

Badriah Abdullah Hifni

Auto-generated profile, based on publicly available information

Badriah Abdullah Hifni

Department of Biology Batterjee Medical College Jeddah Saudi Arabia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2025 in BMC Pharmacology and Toxicology
Verified
Journal Article
Open access
PDF file
EEEkramy Elmorsy
Ekramy Elmorsy
HDHuda Abdulaziz Al Doghaither
Huda Abdulaziz Al Doghaither
AAAyat Al-Ghafari
Ayat Al-Ghafari
BHBadriah Abdullah Hifni
Badriah Abdullah Hifni
DJDr. Najlaa M.M. Jawad
Dr. Najlaa M.M. Jawad
NANagwa Aly
Nagwa Aly
Amphotericin B (Amp-B/FZ), a first-line antifungal, is limited by dose-dependent nephrotoxicity. This study investigated the protective effects of hyperoside (HP), a dietary flavonoid, against FZ-induced renal toxicity in human proximal tubular (HK-2) cells. Molecular docking revealed strong binding affinities of HP with mitophagy (PINK1/PARKIN) and antioxidant (Nrf2/HO-1) regulators, contrasting with FZ’s preferential binding to mitochondrial complex I. FZ (30–60 µM) induced cytotoxicity (MTT/LDH), genotoxicity (comet assay), and bioenergetic disruption: ATP depletion (58%), mitochondrial complex I/III inhibition (42–67%), and PINK1/PARKIN dysregulation. FZ elevated reactive species (3.2-fold) and lipid peroxidation (2.8-fold) while suppressing catalase (64%) and superoxide dismutase (51%) activities. qPCR confirmed FZ-induced downregulation of NDUFS1, CYC1, CAT, and SOD2, alongside impaired Nrf2/HO-1 antioxidant signaling. Co-treatment with HP (20–40 µM) attenuated FZ toxicity, restoring ATP (1.8-fold), mitochondrial complex activities (35–49%), and antioxidant defenses (CAT:2.1-fold, SOD:1.7-fold). HP also normalized Nrf2/HO-1 expression and mitigated oxidative/genotoxic damage. These findings highlight HP’s dual role in countering FZ-induced mitochondrial dysfunction and oxidative stress, positioning it as a promising nephroprotective adjuvant. Further in vivo validation could advance HP’s clinical application in reducing antifungal-associated renal injury.

1 January 2026 in Open Chemistry
Verified
Journal Article
Open access
ZRZeerwah Rajpoot
Zeerwah Rajpoot
MNMuhammad Naveed
Muhammad Naveed
SMSarmad Mahmood
Sarmad Mahmood
AAArooj Azeem
Arooj Azeem
Shafiq RehmanShafiq Rehman
Shafiq Rehman
SAShaza Abdullah Alyamani
Shaza Abdullah Alyamani
Polycystic Ovary Syndrome (PCOS) is a prevalent and complex endocrine disorder affecting reproductive-aged women, characterized by hormonal imbalances, ovarian dysfunction, and metabolic disturbances. This study investigates the biological properties of curcumin-conjugated zinc oxide nanoparticles (Cur-ZnO NPs) synthesized via a green method using Livistona Chinensis leaf extract. Plant extract metabolites acted as natural capping and reducing agents, facilitating the formation of ZnO nanoparticles. The synthesized Cur-ZnO NPs were characterized using UV–vis spectroscopy, Fourier Transform Infrared (FTIR) spectroscopy, Scanning Electron Microscopy (SEM), and Energy Dispersive X-ray (EDX), revealing a spherical morphology with an average size of 30 nm and the presence of zinc oxide groups. In vitro assays demonstrated the biological activities of Cur-ZnO NPs, including 96.17 % antioxidant, 94.45 % anti-inflammatory, 92.72 % α -amylase inhibitory activity, 7 % anti-hemolytic, and significant antimicrobial properties. Computational analyses, including transcriptomic evaluation and molecular docking studies, revealed molecular interactions between the nanoparticles and PCOS associated genes such as MRPS12, RPS18, and RPS5 indicating potential biological relevance. Toxicity predictions indicated low predicted genetic toxicity and carcinogenicity, although these findings are preliminary and require experimental validation. Collectively, this study provides preliminary in vitro and in-silico insights into the biological properties of Green-synthesised Cur-ZnO NPs. Further in vivo studies are required to evaluate their safety, efficacy, and potential biomedical applications.

8 March 2026 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
MAMuhammad Usman Ahmad
Muhammad Usman Ahmad
USUmama Saif
Umama Saif
SASikander Ali
Sikander Ali
Tariq AzizTariq Aziz
Tariq Aziz
NANawal Alhoshani
Nawal Alhoshani
SAShaza Abdullah Alyamani
Shaza Abdullah Alyamani

5 February 2026 in Journal of Computational Biophysics and Chemistry
Verified
Journal Article
Closed access
FAFakhria Abdullah Aljoufi
Fakhria Abdullah Aljoufi
HAHayam Atallah Alwabsi
Hayam Atallah Alwabsi
MMMariam Ameen Mojally
Mariam Ameen Mojally
HSHina Sarfraz
Hina Sarfraz
YKYousaf Khan
Yousaf Khan
RHRafaqat Hussain
Rafaqat Hussain